Image showing sections of cerebral brain organoids derived from pluripotent stem cells.
via Agnieszka Rybak-Wolf, MDC/LifeTime
Hundreds of researchers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In a perspective in Nature and the LifeTime Strategic Research Agenda they now present a roadmap of how to leverage the latest scientific breakthroughs and technologies over the next decade, to track, understand and treat human cells throughout an individual’s lifetime.
The LifeTime initiative, co-coordinated by the Max Delbrück Center of Molecular Medicine in the Helmholtz Association (MDC) in Berlin and the Institut Curie in Paris, has developed a strategy to advance personalized treatment for five major disease classes: cancer, neurological, infectious, chronic inflammatory and cardiovascular diseases. The aim is a new age of personalized, cell-based interceptive medicine for Europe with the potential of improved health outcomes and more cost-effective treatment, resulting in profoundly changing a person’s healthcare experience.
Earlier detection and more effective treatment of diseases
To form a functioning, healthy body, our cells follow developmental paths during which they acquire specific roles in tissues and organs. But when they deviate from their healthy course, they accumulate changes leading to disease which remain undetected until symptoms appear. At this point, medical treatment is often invasive, expensive and inefficient. However, now we have the technologies to capture the molecular makeup of individual cells and to detect the emergence of disease or therapy resistance much earlier.
Using breakthrough single-cell and imaging technologies in combination with artificial intelligence and personalized disease models will allow us to not only predict disease onset earlier, but also to select the most effective therapies for individual patients. Targeting disease-causing cells to intercept disorders before irreparable damage occurs will substantially improve the outlook for many patients and has the potential of saving billions of Euros of disease-related costs in Europe.
A detailed roadmap for implementing LifeTime
The perspective article “The LifeTime initiative and the future of cell-based interceptive medicine in Europe” and the LifeTime Strategic Research Agenda (SRA) explain how these technologies should be rapidly co-developed, transitioned into clinical settings and applied to the five major disease areas. Close interactions between European infrastructures, research institutions, hospitals and industry will be essential to generate, share and analyze LifeTime’s big medical data across European borders. The initiative’s vision advocates ethically responsible research to benefit citizens all across Europe.
According to Professor Nikolaus Rajewsky, scientific director of the Berlin Institute for Medical System Biology at the Max Delbrück Center for Molecular Medicine and coordinator of the LifeTime Initiative, the LifeTime approach is the way into the future: “LifeTime has brought together scientists across fields – from biologists, to clinicians, data scientists, engineers, mathematicians, and physicists – to enable a much improved understanding of molecular mechanisms driving health and disease. Cell-based medicine will allow doctors to diagnose diseases earlier and intercept disorders before irreparable damage has occurred. LifeTime has a unique value proposition that promises to improve the European patient’s health.”
Dr. Geneviève Almouzni, director of research at CNRS, honorary director of the research center from Institut Curie in Paris and co-coordinator of the LifeTime Initiative believes that the future with LifeTime offers major social and economic impact: “By implementing interceptive, cell-based medicine we will be able to considerably improve treatment across many diseases. Patients all over the world will be able to lead longer, healthier lives. The economic impact could be tremendous with billions of Euros saved from productivity gains simply for cancer, and significantly shortened ICU stays for Covid-19. We hope EU leaders will realize we have to invest in the necessary research now.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cell-based interceptive medicine
- Stem Cells News
Genetically Modified Pluripotent Stem Cells May Evade Immunological Rejection After Transplantation, Study Shows Jan. 11, 2024 — One of the biggest barriers to regenerative medicine is ...
- CAR T-Cell Therapy for Glioblastoma
1 report the outcomes of treating three patients with a secreting chimeric antigen receptor (CAR) T cell (see Key Concepts). CAR T-cell technology has reshaped our therapeutic approach to ...
- HeLa cells: The most influential and controversial discovery in medicine
These are just a few of the life-changing developments in medicine made possible by the cells of Henrietta Lacks. One would imagine the compensation and rewards for providing such an incredible ...
- Discovery could revolutionize stem cell-based brain repair therapy for Parkinson's disease
Neuroscientists at University of Galway have made an exciting discovery that could revolutionize stem cell-based brain repair ... advancements in regenerative medicine and stem cell technology ...
- Stem Cells in Reproductive Medicine
Check if you have access via personal or institutional login Stem cell science has the potential to impact human reproductive medicine significantly – cutting edge technologies allow the production ...
Go deeper with Google Headlines on:
Cell-based interceptive medicine
[google_news title=”” keyword=”cell-based interceptive medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
LifeTime Initiative
- FDA wants to advance health equity through home-based care
The FDA announced an initiative to reimagine the home environment as an integral part of the healthcare system and promote health equity.
- Truth Initiative Partners with Pennsylvania's Office of Attorney General to Provide Prescription Drug Safety Course, Powered by EVERFI from Blackbaud
Truth Initiative, the organization behind truth®, the nationally recognized, proven-effective youth tobacco and opioid prevention public education campaigns, and EVERFI® from Blackbaud®, the leader in ...
- Midland College announces executive director of new College & Career Connections Initiative
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
- Lifetime Achievement award for Birketts lawyer
Kath Herbert from Birketts LLP was presented with the most prestigious award of the night at the Cambridgeshire Law Society (CLS) annual presentation dinner at King’s College.
- Initiative aims to provide 'prescription for wellness' by getting more people outside
A community health initiative partnered with the National Park Service, ParkRx, is trying to get patients outside to support their mental and physical health.
Go deeper with Google Headlines on:
LifeTime initiative
[google_news title=”” keyword=”LifeTime initiative” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]